Diffuse panbronchiolitis: role of macrolides in therapy.


Diffuse panbronchiolitis (DPB) is characterized by chronic sinobronchial infection and diffuse bilateral micronodular pulmonary lesions consisting of inflammatory cells. Studies on disease etiology point to a genetic predisposition unique to Asians. Early therapy for DPB was largely symptomatic. The advent of macrolide antibiotics, including erythromycin… (More)


Cite this paper

@article{Keicho2002DiffusePR, title={Diffuse panbronchiolitis: role of macrolides in therapy.}, author={Naoto Keicho and Shoji Kudoh}, journal={American journal of respiratory medicine : drugs, devices, and other interventions}, year={2002}, volume={1 2}, pages={119-31} }